Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2005
09/28/2005EP1580556A1 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration
09/28/2005EP1580555A1 Magnetic particle collecting magnetic force body and its use
09/28/2005EP1580554A1 Method of immobilizing polynucleotide on solid support, solid immobilization support thus obtained, method of detecting target polynucleotide from the solid support and solution for immobilizing polynucleotide
09/28/2005EP1580553A1 Method of assaying elastin digestion product and assay kit, method of detecting aortic dissection and detection kit
09/28/2005EP1580552A1 Microfluidic analytical system with position electrodes
09/28/2005EP1580551A1 Plasma or serum separation membrane and filter apparatus including the plasma or serum separation membrane
09/28/2005EP1580550A2 Method of determining a property characteristic for the viscosity of a combustion engine oil
09/28/2005EP1580544A1 Examining device for water resistant, air-permeable cloth
09/28/2005EP1580282A1 Use of human RPS6KA6-related gene variant for diagnosing T cell lymphoblastic lymphoma
09/28/2005EP1580279A1 Method of measuring lipid in specific lipoprotein
09/28/2005EP1580271A2 Human Orphan G Protein-Coupled Receptors
09/28/2005EP1580269A1 Method of detecting gene mutation
09/28/2005EP1580266A1 Screening method
09/28/2005EP1580265A1 Nucleic acids isolated from neuroblastoma at stage 4s
09/28/2005EP1580196A1 Monitor protein for measuring processing of protein
09/28/2005EP1579926A2 Apparatus supplying liquid drops to predetermined positions on a substrate
09/28/2005EP1579506A2 Water soluble metal and semiconductor nanoparticle complexes
09/28/2005EP1579383A2 Binary prediction tree modeling with many predictors and its uses in clinical and genomic applications
09/28/2005EP1579373A2 Optical tomography of small objects using parallel ray illumination and post-specimen optical magnification
09/28/2005EP1579223A2 Transport device for transporting test strips in an analysis system
09/28/2005EP1579222A1 Non-competitive immunoassay for small analytes
09/28/2005EP1579221A2 Uses of hmgb, hmgn, hmga proteins
09/28/2005EP1579220A2 Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
09/28/2005EP1579219A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 2c (5-ht2c)
09/28/2005EP1579218A2 Method of modulation of interaction between receptor and ligand
09/28/2005EP1579217A1 Method of determining site-specificity and kit therefor
09/28/2005EP1579216A2 Loc169505 as modifier of the apc and axin pathways and methods of use
09/28/2005EP1579215A2 Methods of biosensing using fluorescent polymers and quencher-tether-ligand bioconjugates
09/28/2005EP1579214A2 Methods of screening for anti-inflammatory drugs and use thereof
09/28/2005EP1579213A1 Method of diagnosis,treatment and useful agents for conditions characterised by modulation in the level of activin beta c.
09/28/2005EP1579212A2 Methods of identifying reduced internalization transmembrane receptor agonists
09/28/2005EP1579211A1 Microporous filtration based dot immunoassay device for method for screening of analytes and method of use
09/28/2005EP1579210A1 Colorimetric sensors constructed of diacetylene materials
09/28/2005EP1579209A2 Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle
09/28/2005EP1579208A1 Analyzing system for the detection of reducing and oxidizing gases in a carrier gas with a metal-oxide-semiconductor sensor arrangement
09/28/2005EP1579207A2 Measurement of total reactive isocyanate groups in samples using bifunctional nucleophiles such as 1,8-diaminonaphthalene (dan)
09/28/2005EP1579204A1 Manufacture of electrochemical sensors by moveable flat screen printing
09/28/2005EP1579194A2 Enhanced scheduling sample processing system and methods of biological slide processing
09/28/2005EP1579191A2 Method and apparatus for separation of particles in a microfluidic device
09/28/2005EP1579188A2 Semipermeable membrane-based sampling systems
09/28/2005EP1579186A2 Identification of kinase inhibitors
09/28/2005EP1579013A2 Method for profiling and identifying persons by using data samples
09/28/2005EP1579012A2 Monitoring high-risk environments
09/28/2005EP1579010A2 Susceptibility gene for myocardial infarction; methods of treatment
09/28/2005EP1579004A2 Screening methods for identification of efficient pre-trans-splicing molecules
09/28/2005EP1579000A1 Magnetism based nucleic acid amplification
09/28/2005EP1578999A2 Molecules and methods using same for measuring non-transferrin bound iron
09/28/2005EP1578994A2 Methods for identifying dna copy number changes
09/28/2005EP1578993A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN
09/28/2005EP1578992A2 Methods of determining precise herg interactions and aletring compounds based on said interactions
09/28/2005EP1578991A2 Methods of diagnosing & treating diabetes and insulin resistance
09/28/2005EP1578987A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
09/28/2005EP1578982A2 Nucleic acid amplification methods
09/28/2005EP1578981A2 Tumor endothelial marker 7alpha molecules and uses thereof
09/28/2005EP1578980A2 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer
09/28/2005EP1578962A2 Carrier-ligand fusions and uses thereof
09/28/2005EP1578961A2 Bindingzyme arrays and high-throughput proteomic methods
09/28/2005EP1578960A1 Magnetism based rapid cell separation
09/28/2005EP1578950A2 Methods for crystallographic structure determination employing hydrogen exchange analysis
09/28/2005EP1578948A2 Flj10607 as modifier of the axin pathway and methods of use
09/28/2005EP1578945A2 Cct6s as modifiers of the rb pathway and methods of use
09/28/2005EP1578941A2 Csnks as modifiers of the rac pathway and methods of use
09/28/2005EP1578940A2 Methods and compositions for diagnosing dysplasia
09/28/2005EP1578934A2 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
09/28/2005EP1578931A2 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinase
09/28/2005EP1578929A2 Nematode phosphoethanolamine n-methyltransferase-like sequences
09/28/2005EP1578924A2 Genomic screen for epigenetically silenced tumor suppressor genes
09/28/2005EP1578923A2 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions
09/28/2005EP1578922A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
09/28/2005EP1578921A2 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
09/28/2005EP1578920A2 Composition and method for modulating an inflammatory response
09/28/2005EP1578919A2 Endogenous retrovirus up-regulated in prostate cancer
09/28/2005EP1578914A2 Human ion channels
09/28/2005EP1578911A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
09/28/2005EP1578910A2 Nitrilases
09/28/2005EP1578906A2 Afap sequences, polypeptides, antibodies and methods
09/28/2005EP1578904A2 Systems, methods and kits for remote genetic analysis and consultation
09/28/2005EP1578903A2 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
09/28/2005EP1578902A2 Neurotransmission-associated proteins
09/28/2005EP1578899A2 Secreted proteins
09/28/2005EP1578896A2 Electro-optical nucleic acid-based sensor array and method for detecting analytes
09/28/2005EP1578799A2 Antibodies directed to tumor necrosis factor and uses thereof
09/28/2005EP1578798A1 Ghrelin receptor inverse agonist for regulation of feeding behaviours
09/28/2005EP1578794A1 A novel phosphoprotein
09/28/2005EP1578793A1 Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
09/28/2005EP1578781A2 Process for determining target function and identifying drug leads
09/28/2005EP1578778A2 Ghrelin analogs
09/28/2005EP1578775A2 Novel compositions and methods for the generation of mhc class ii compounds by peptide exchange
09/28/2005EP1578773A2 Methods and products based on oligomerization of stress proteins
09/28/2005EP1578772A2 Cytokines and cytokine receptors with reduced immunogenicity
09/28/2005EP1578760A2 Compositions and methods for the diagnosis and treatment of tumor
09/28/2005EP1578723A2 Process for the preparation of oxazolidinones and method of use thereof
09/28/2005EP1578687A2 Crystalline structure of human mapkap kinase-2
09/28/2005EP1578612A2 Ink composition for use in a continuous web process for the manufacture of electrochemical sensors
09/28/2005EP1578527A1 Preparation and use of mixed mode solid substrates for chromatography adsorbents and biochip arrays
09/28/2005EP1578456A1 Isotope labeled camptothecin derivatives
09/28/2005EP1578446A2 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
09/28/2005EP1578444A2 Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis
09/28/2005EP1578411A1 Methods for selectively inhibiting janus tyrosine kinase 3 (jak3)
09/28/2005EP1578397A2 Human monoclonal antibodies against cd25